Ethnic-Related Characteristics of Lipid and Carbohydrate Metabolism in the Indigenous Population of Yakutia

Sargylana I. Sofronova, Maria P. Kirillina, Vyacheslav M. Nikolaev, Anna N. Romanova, Matrena N. Mikhailova, Irina V. Kononova

International Journal of Biomedicine. 2020;10(1):58-60.
DOI: 10.21103/Article10(1)_OA9
Originally published March 15, 2020


Background: The objective of our research was to study the ethnic-related characteristics of lipid and carbohydrate metabolism in the indigenous population of Yakutia.
Methods and Results: The study was conducted under expeditionary conditions in the North of Yakutia (Nizhnekolymsky, Anabarsky, Verkhnekolymsky, Tomponsky, and Srednekolymsky districts). In total, 529 people aged between 20 and 70 years were examined in the primary health care units. For a comparative analysis, we formed 6 ethnic groups (Yakuts, Evenks, Evens, Dolgans, Chukchi, Yukagirs). In all ethnic groups, there was a high prevalence of atherogenic dyslipidemia, with the highest frequency in Evenks and Yakuts. Women had a higher frequency of lipid metabolism disorders than men did. The frequency of hyperglycemia was significantly higher among the Dolgans, Evenks and Yakuts than in other ethnic groups.
Conclusion: This study showed a high frequency of MetS in the examined ethnic groups, which is caused by a change in the traditional lifestyle and the nature of nutrition.

hypercholesterolemia • hyperglycemia • indigenous population • Yakutia
  1. Health care in the Republic of Sakha (Yakutia): Statistical collection / Sakha (Yakutia) stat. Yakutsk, 2016. [In Russian].
  2. Aronov DM, Arabidze GG, Akhmedzhanov NM, Balakhonova TV, Boytsov SA, Bubnova MG , et al. Russian recommendations. Revision V. Russian Cardiology Journal. 2012; 5 (97): 1-32. [In Russian].
  3. European Association for Cardiovascular Prevention & Rehabilitation, Reiner Z, Catapano AL, De Backer G, Graham I, Taskinen MR, Wiklund O, et al.; ESC Committee for Practice Guidelines (CPG) 2008-2010 and 2010-2012 Committees. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J. 2011 Jul;32(14):1769-818. doi: 10.1093/eurheartj/ehr158.
  4. Lorenzo C, Williams K, J. Hunt K, M. Haffner S. The National Cholesterol Education Program - Adult Treatment Panel III, International Diabetes Federation, and World Health Organization Definitions of the Metabolic Syndrome as Predictors of Incident Cardiovascular Disease and Diabetes. Diabetes Care. 2007;30(1):8-13.
  5. Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care. 2005;28(7):1769-78.
  6. Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK, Montori VM. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol. 2007;49(4):403-14.
  7. Mamedov MN, Oganov RG. [Epidemiological aspects of the metabolic syndrome]. Kardiologiia. 2004; 44(9):4-8. [Article in Russian].
  8. Muromtseva GA, Kontsevaya AV, Konstantinov VV, Artamonova GV, Gatagonova TM, Duplyakov DV, et al. [The prevalence of non-infectious diseases risk factors in Russian population in 2012-2013 years. The results of ECVD-RF]. Cardiovascular Therapy and Prevention. 2014;13(6):4-11.[Article in Russian].
  9. Scientific and organizational committee of the project ESSE-RF. Epidemiology of cardiovascular diseases in different regions of Russia (ESSE-RF). The rationale for and design of the study. Russian Journal of Preventive Medicine and Public Health. 2013;16(6):25-34. [Article in Russian].

Download Article
Received January 16, 2020.
Accepted February 17, 2020.
©2020 International Medical Research and Development Corporation.